Out of Specification

Out Of Specification Investigation Phase II (MHRA)

Out Of Specification Investigation Phase II (MHRA) Conducted when the phase I investigations did not  reveal an assignable laboratory error.  Phase II investigations are driven by written and approved instructions against hypothesis.  Prior to further testing a manufacturing investigation should be started to determine whether there was a possible manufacturing root cause. If not already

Out Of Specification Investigation Phase II (MHRA) Read More »

Out Of Specification Investigation Phase Ia & Phase Ib (MHRA)

Out Of Specification Investigation Phase Ia & Phase Ib (MHRA) Phase Ia Investigation Definition: Out of Specification Investigation Phase la investigation is to determine whether there has been a clear obvious errors due to external circumstances such as power failure or those that the analyst has detected prior to generating data such as spilling sample

Out Of Specification Investigation Phase Ia & Phase Ib (MHRA) Read More »

Out of Specification &Out of Trend Investigations (MHRA)

Out of Specification &Out of Trend Investigations (MHRA) Laboratory Analysis Investigations of “Out of Specification (OOS) / Out of Trend (OOT)/ Atypical results” have to be done in cases of: Batch release testing and testing of starting materials. In-Process Control testing: if data is used for batch calculations/decisions and if in a dossier and on

Out of Specification &Out of Trend Investigations (MHRA) Read More »

How to Investigate Out Of Specification(OOS) Test Results….??? ( USFDA Phase -II)

How to Investigate Out Of Specification(OOS) Test Results….??? ( USFDA Phase -II) Out Of Specification( OOS ) :-  The all test results which goes outside the specification or acceptance criteria established in Drug Dossiers, Drug Master files, Its official Pharmacopeias, Or the manufacturer comes Under Out of Specification( OOS ). We have seen in last

How to Investigate Out Of Specification(OOS) Test Results….??? ( USFDA Phase -II) Read More »

How to Investigate Out Of Specification(OOS) Test Results….???( USFDA Phase -I)

How to Investigate Out Of Specification(OOS) Test Results….??? ( USFDA Phase -I) Out Of Specification(OOS) :-  The all test results which goes outside the specification or acceptance criteria established in Drug Dossiers, Drug Master files, Its official Pharmacopeias, Or the manufacturer comes Under Out of Specification(OOS).   What USFDA guideline says about Investigation of Out

How to Investigate Out Of Specification(OOS) Test Results….???( USFDA Phase -I) Read More »